Browsing "School of Medicine" by Author Packer, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
PreviewIssue DateTitleAuthor(s)
2000Acute coronary findings at autopsy in heart failure patients with sudden death : results from the assessment of treatment with lisinopril and survival (ATLAS) trialUretsky, B.; Thygesen, K.; Armstrong, P.; Cleland, J.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.; Ryden, L.
2001Cardiovascular critical event pathways for the progression of heart failure; A report from the ATLAS studyCleland, J.; Thygesen, K.; Uretsky, B.; Armstrong, P.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.; Ryden, L.
2005Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United KingdomStewart, S.; McMurray, J.; Hebborn, A.; Coats, A.; Packer, M.
1999Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failurePacker, M.; Poole-Wilson, P.; Armstrong, P.; Cleland, J.; Horowitz, J.; Massie, B.; Ryden, L.; Thygesen, K.; Uretsky, B.
2000Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitusRyden, L.; Armstrong, P.; Cleland, J.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.
2001Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trialMassie, B.; Armstrong, P.; Cleland, J.; Horowitz, J.; Packer, M.; Poole-Wilson, P.; Ryden, L.